NASDAQ: PRENW - Prenetics Holding Company Limited

Yield per half year: 0%
Dividend yield: 0.00%

Share chart Prenetics Holding Company Limited

Extended chart Simple chart
Financial Markets by TradingView

About Prenetics Holding Company Limited

Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company's consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes Insighta, a multi-cancer early detection technology. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTDrug tests.

more details
Further, the company offers ACTLiquid Pro, a sequencing based liquid biopsy assay for pan-solid tumors; ACTMonitor, which provides real time monitoring of drug resistance, treatment response, and cancer recurrence; and ACT Risk, which manages the cancer risk. It operates in Taiwan, Hong Kong, the United Kingdom, and internationally. The company was founded in 2014 and is based in Quarry Bay, Hong Kong and has a presence in the United States.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2022-05-18
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.prenetics.com
Цена ао 0.0104
Change price per day: 0% (0.0108)
Change price per week: +11.34% (0.0097)
Change price per month: -22.3% (0.0139)
Change price per 3 month: +9.09% (0.0099)
Change price per half year: 0% (0.0108)
Change price per year: +47.95% (0.0073)
Change price per year to date: -2.7% (0.0111)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 135.49 10
Yield Ebitda, % 158.67 10
Yield EPS, % 104.33 10
Total: 10
More

Head Job title Payment Year of birth
Mr. Sheng Wu Yeung Co-Founder, Chairperson & CEO 1979 (46 years)
Dr. Chi Hung Tzang Ph.D. Co-Founder & Chief Scientific Officer 1974 (51 year)
Mr. Hoi Chun Lo Chief Financial Officer 1985 (40 years)
Ms. Samantha Kwok Chief of Staff to Group CEO & Vice President of People & Operations
Dr. Yung Ho Wong DPHIL Chief Technology Officer 1982 (43 years)
Dr. Senthil Sundaram M.D. Chief Clinical Officer 1974 (51 year)
Mr. Joel Neoh Chief Consumer Officer & CEO for CircleDNA 1984 (41 year)
Mr. Walt Ling Chief Executive Officer of ACT Genomics

Address: Hong Kong, Quarry Bay, Unit 703-706 K11 Atelier King’s Road - open in Google maps, open in Yandex maps
Website: https://www.prenetics.com